Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 3
2009 1
2011 2
2012 3
2014 1
2015 1
2016 4
2018 3
2019 2
2020 3
2021 1
2022 3
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Results by year

Filters applied: . Clear all
Page 1
Design of Mesoporous Silica Nanoparticles for the Treatment of Amyotrophic Lateral Sclerosis (ALS) with a Therapeutic Cocktail Based on Leptin and Pioglitazone.
Díaz-García D, Ferrer-Donato Á, Méndez-Arriaga JM, Cabrera-Pinto M, Díaz-Sánchez M, Prashar S, Fernandez-Martos CM, Gómez-Ruiz S. Díaz-García D, et al. Among authors: prashar s. ACS Biomater Sci Eng. 2022 Nov 14;8(11):4838-4849. doi: 10.1021/acsbiomaterials.2c00865. Epub 2022 Oct 14. ACS Biomater Sci Eng. 2022. PMID: 36240025 Free PMC article.
Dual Anticancer and Antibacterial Properties of Silica-Based Theranostic Nanomaterials Functionalized with Coumarin343, Folic Acid and a Cytotoxic Organotin(IV) Metallodrug.
Ugalde-Arbizu M, Aguilera-Correa JJ, García-Almodóvar V, Ovejero-Paredes K, Díaz-García D, Esteban J, Páez PL, Prashar S, San Sebastian E, Filice M, Gómez-Ruiz S. Ugalde-Arbizu M, et al. Among authors: prashar s. Pharmaceutics. 2023 Feb 7;15(2):560. doi: 10.3390/pharmaceutics15020560. Pharmaceutics. 2023. PMID: 36839883 Free PMC article.
Synthesis of a theranostic platform based on fibrous silica nanoparticles for the enhanced treatment of triple-negative breast cancer promoted by a combination of chemotherapeutic agents.
Ovejero-Paredes K, Díaz-García D, Mena-Palomo I, Marciello M, Lozano-Chamizo L, Morato YL, Prashar S, Gómez-Ruiz S, Filice M. Ovejero-Paredes K, et al. Among authors: prashar s. Biomater Adv. 2022 Jun;137:212823. doi: 10.1016/j.bioadv.2022.212823. Epub 2022 Apr 25. Biomater Adv. 2022. PMID: 35929238 Free article.
29 results